BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 15637654)

  • 1. [Intensive care support of patients after stem cell transplantation].
    Wrede CE; Holler E
    Intensivmed Notfallmed; 2007; 44(3):129-141. PubMed ID: 32287638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality.
    Sakellari I; Gavriilaki E; Papagiannopoulos S; Gavriilaki M; Batsis I; Mallouri D; Vardi A; Constantinou V; Masmanidou M; Yannaki E; Smias C; Geroukis T; Kazis D; Kimiskidis V; Anagnostopoulos A
    J Neurol; 2019 Aug; 266(8):1960-1972. PubMed ID: 31087160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome.
    Lin TA; Gau JP; Liu YC; Ko PS; Wang HY; Chien SH; Liu CJ; Hsiao LT; Chiou TJ; Liu JH
    Int J Hematol; 2019 May; 109(5):584-592. PubMed ID: 30864116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact.
    Dowling MR; Li S; Dey BR; McAfee SL; Hock HR; Spitzer TR; Chen YB; Ballen KK
    Bone Marrow Transplant; 2018 Feb; 53(2):199-206. PubMed ID: 29131150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous Hematopoietic Stem Cell Transplantation-10 Years of Data From a Developing Country.
    Ali N; Adil SN; Shaikh MU
    Stem Cells Transl Med; 2015 Aug; 4(8):873-7. PubMed ID: 26032748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The double-edged sword: Neurotoxicity of chemotherapy.
    Magge RS; DeAngelis LM
    Blood Rev; 2015 Mar; 29(2):93-100. PubMed ID: 25445718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological complications of transplantation: part I: hematopoietic cell transplantation.
    Pruitt AA; Graus F; Rosenfeld MR
    Neurohospitalist; 2013 Jan; 3(1):24-38. PubMed ID: 23983885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain imaging findings in symptomatic patients after allogeneic haematopoietic stem cell transplantation: correlation with clinical outcome.
    Chen BT; Ortiz AO; Dagis A; Torricelli C; Parker P; Openshaw H
    Eur Radiol; 2012 Oct; 22(10):2273-81. PubMed ID: 22618523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases.
    Voss M; Bischof F
    BMC Neurol; 2010 Sep; 10():76. PubMed ID: 20809972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-mediated myelopathy following allogeneic stem cell transplantation.
    Sakai M; Ohashi K; Ohta K; Yamashita T; Akiyama H; Kisida S; Kamata N; Sakamaki H
    Int J Hematol; 2006 Oct; 84(3):272-5. PubMed ID: 17050204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system infections in transplantation.
    Czartoski T
    Curr Treat Options Neurol; 2006 May; 8(3):193-201. PubMed ID: 16569378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurological complications of transplantation].
    Martínez-Hernández E; Rosenfeld MR; Pruitt A; Dalmau J
    Neurologia; 2008; 23(6):373-86. PubMed ID: 18597192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
    Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological complications of hematopoietic cell transplantation.
    Saiz A; Graus F
    Semin Neurol; 2004 Dec; 24(4):427-34. PubMed ID: 15637654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic complications of hematopoietic cell transplantation.
    Saiz A; Graus F
    Semin Neurol; 2010 Jul; 30(3):287-95. PubMed ID: 20577935
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.